Clinical Trials Browser

Carcinoma, Hepatocellular × Radiation Dose Hypofractionation × Gastrointestinal × Clear all

NCT04430452 2025-12-08

Durvalumab With/Without Tremelimumab After Palliative Hypofractionated Radiotherapy for Hepatocellular Carcinoma

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular